Chimeric antigen receptor macrophages: a new frontier in hepatocellular carcinoma treatment
Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related mortality worldwide[1][1]. The primary treatment options for this disease are surgical resection and liver transplantation. Unfortunately, most HCC cases are diagnosed in advanced stages and are inoperable. Even after
Authors
- Terence K. Lee (ORCID: https://orcid.org/0000-0003-0682-322X)
- Clarence T. T. Wong (ORCID: https://orcid.org/0000-0001-8950-0033)
- Rainbow Wing Hei Leung
Institutions
- Hong Kong Polytechnic University (HK)
Publication Details
- Journal
- Cancer Biology and Medicine
- Published
- 2025-09-29
- DOI
- https://doi.org/10.20892/j.issn.2095-3941.2025.0427
- Citations
- 1
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 1.05
Funders
- Impact Fund